Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
C-MER Eye Care Holdings Limited ( (HK:3309) ) has issued an announcement.
C-MER Medical Holdings Limited has announced the acquisition of a 58% stake in Hong Kong Endoscopy Centre, a well-established facility offering gastroscopy, colonoscopy, and cystoscopy services. This strategic acquisition aims to expand C-MER’s medical services in Hong Kong, leveraging existing patient bases to create synergies with its operations in Hong Kong and Shenzhen, ultimately benefiting the company’s shareholders.
The most recent analyst rating on (HK:3309) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on C-MER Eye Care Holdings Limited stock, see the HK:3309 Stock Forecast page.
More about C-MER Eye Care Holdings Limited
C-MER Medical Holdings Limited is a company operating in the healthcare industry, primarily focusing on eye care services. It is headquartered in Hong Kong and engages in providing specialized medical services, including endoscopy, through its subsidiaries.
Average Trading Volume: 988,350
Technical Sentiment Signal: Hold
Current Market Cap: HK$2.55B
Learn more about 3309 stock on TipRanks’ Stock Analysis page.